Abbott Laboratories remains a top pick in volatile markets thanks to strong fundamentals and regulatory tailwinds.

For many, a partnership between Abbott and Medtronic, two medtech giants and frequent competitors, would have seemed unlikely.

Abbott announced today that it entered a first-of-its-kind agreement to integrate data from its Libre systems into Epic EHR systems.

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

Coca-Cola, Abbott Laboratories, RTX, Investors Title and Armanino Foods of Distinction are part of the Zacks top Analyst Blog.

Abbott Laboratories announced a plan to invest $500 million to expand its U.S. manufacturing footprint. The medical device maker will upgrade facilities in both Illinois and Texas to expand its ...

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Suburban-based Abbott Laboratories says it will spend $500 million on two manufacturing facilities, including one in ...

Abbott Laboratories (NYSE: ABT) Q1 2025 Earnings Conference Call April 16, 2025 9:00 AM ET Company Participants Mike Comilla - VP, IR Robert Ford - Chairman and CEO Phil Boudreau - EVP, Finance ...

From adverse plant inspections to glaring gaps in its heart device product line, Abbott Laboratories is steadily working to resolve the unfinished business of former Minnesota medical device maker ...